MLTO Medirect Latino Inc (CE)

MEDirect Latino Inc. (OTC:MLTO) - http://www.medirectlatino.org, today announced an investor conference call to be held on Wednesday, August 10, 2005 at 4:15 PM Eastern Daylight Time. MEDirect Latino's management team will host the call. Co-Chairman and CEO, Mr. Raymond Talarico, President, Ms. Debra L. Towsley and COO, Mr. Charles W. Hansen, will be making presentations on various aspects of the Company's latest results. "We are very excited about recent developments; we have added additional branded, Spanish packaged, diagnostic testing products for our Hispanic Medicare customer and have expanded our business model to include the rollup of Medicare beneficiaries enrolled in PPO and HMO managed care programs," stated Mr. Talarico. Adding, "MEDirect continues to fulfill the critical link between the Hispanic Medicare community and their healthcare benefits." Company President, Ms. Debra L. Towsley, noted, "We have a commitment to our shareholders as well as the investment community for maximum disclosure and communication, and for that reason we are looking forward to discussing these developments with our Shareholders and the investment community." MEDirect Latino (OTC:MLTO) - http://www.medirectlatino.org - is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the US Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure. The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion). Interested parties may hear the conference call by telephone. -0- *T Instructions for hearing the conference call: To hear the conference call as it takes place: Call 1-800-434-1335 in the United States or Canada or; Call 1-404-920-6620 in the Atlanta Area or Internationally Pin Code: 078975 Exclusive: For Expedited Entry into the Conference: Please register via this link for your Direct Access 800 number. http://www.AccuConference.com/MLTO To hear a recording of the call (available immediately following the call by telephone for 30 days after the call takes place): Call 1-800-977-8002 in the United States or Canada or; Call 1-404-920-6650 in the Atlanta Area or Internationally Pin Code: Press the star key then 078975 *T Forward Looking Statements: Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; the Company will appropriately inform the public.